Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.28B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.02B |
| 3 |
Bank of America
BAC
|
+$770M |
| 4 |
Gilead Sciences
GILD
|
+$378M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$346M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$973M |
| 3 |
Walt Disney
DIS
|
+$588M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
AT&T
T
|
+$529M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.4% |
| 2 | Healthcare | 3.08% |
| 3 | Financials | 2.41% |
| 4 | Consumer Discretionary | 2.33% |
| 5 | Industrials | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12476
Cadrenal Therapeutics
CVKD
$6.67M
| $34.1K | ﹤0.01% |
+3,723
| New | +$47.2K |
|
|
GB
12477
PUT
DELISTED
Global Blue Group Holding
GB
| $34.1K | ﹤0.01% |
6,500
+4,600
| +242% | +$21.4K |
|
12478
CALL
Cato Corp
CATO
$67.9M
| $34K | ﹤0.01% |
5,900
-9,400
| -61% | -$62.7K |
|
|
FLZH
12479
Flash Sports & Media Holdings
FLZH
$71.1M
| $34K | ﹤0.01% |
994
-128
| -11% | -$6.22K |
|
12480
CALL
OptimizeRx
OPRX
$164M
| $34K | ﹤0.01% |
2,800
-27,100
| -91% | -$393K |
|
|
BHR
12481
PUT
Braemar Hotels & Resorts
BHR
$139M
| $34K | ﹤0.01% |
17,000
+3,200
| +23% | +$7.07K |
|
12482
PUT
Fulcrum Therapeutics
FULC
$285M
| $34K | ﹤0.01% |
3,600
-4,100
| -53% | -$36.6K |
|
|
LVTX
12483
CALL
DELISTED
LAVA Therapeutics
LVTX
| $34K | ﹤0.01% |
+10,200
| New | +$22.4K |
|
|
STRR
12484
DELISTED
Star Equity Holdings
STRR
| $33.9K | ﹤0.01% |
7,650
-1,292
| -14% | -$6.15K |
|
12485
PUT
Electromed
ELMD
$341M
| $33.9K | ﹤0.01% |
+2,100
| New | +$27.6K |
|
12486
PUT
MarketWise
MKTW
$54.2M
| $33.9K | ﹤0.01% |
980
+445
| +83% | +$18.9K |
|
|
CSCI
12487
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $33.9K | ﹤0.01% |
3,960
+1,459
| +58% | +$11.2K |
|
12488
Reading International Class A
RDI
$36.6M
| $33.8K | ﹤0.01% |
18,372
-1,795
| -9% | -$3.41K |
|
|
TPIC
12489
DELISTED
TPI Composites
TPIC
| $33.7K | ﹤0.01% |
11,594
+834
| +8% | +$2.46K |
|
12490
PUT
Genius Sports
GENI
$2.33B
| $33.7K | ﹤0.01% |
5,900
-34,800
| -86% | -$224K |
|
|
VXRT
12491
PUT
DELISTED
Vaxart
VXRT
| $33.7K | ﹤0.01% |
25,900
+7,100
| +38% | +$7.44K |
|
12492
PUT
Sabesp
SBS
$16.2B
| $33.7K | ﹤0.01% |
+10,313
| New | +$31.5K |
|
12493
PUT
Banner Corp
BANR
$2.52B
| $33.6K | ﹤0.01% |
700
-400
| -36% | -$18.7K |
|
12494
CALL
Maximus
MMS
$2.89B
| $33.6K | ﹤0.01% |
400
-200
| -33% | -$16.5K |
|
12495
CALL
BioXcel Therapeutics
BTAI
$36.7M
| $33.6K | ﹤0.01% |
744
-2,850
| -79% | -$136K |
|
12496
CALL
Ultralife
ULBI
$125M
| $33.5K | ﹤0.01% |
3,800
+2,900
| +322% | +$23.6K |
|
12497
PUT
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
| $33.5K | ﹤0.01% |
800
-2,000
| -71% | -$81.6K |
|
|
SELX
12498
DELISTED
Semilux International
SELX
| $33.4K | ﹤0.01% |
+21,170
| New | +$31.1K |
|
12499
CALL
ProFrac Holding
ACDC
$978M
| $33.4K | ﹤0.01% |
4,000
+1,900
| +90% | +$14.6K |
|
|
AGEN
12500
PUT
Agenus
AGEN
$329M
| $33.4K | ﹤0.01% |
2,880
+460
| +19% | +$6.1K |
|
Similar funds
Ken Griffin's Q1 2024 Portfolio in Review
As of Q1 2024, Ken Griffin held 15,912 positions worth $518B, up 3.6% from $500B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin withdrew a net $36B in Q1 2024, closing 1,439 positions and reducing 6,148 holdings. Its most notable exit was iShares National Muni Bond ETF, an estimated $183M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.8% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in TD Synnex worth $245M.
- Ken Griffin's largest Q1 2024 buy was TD Synnex: 2,162,840 shares worth $245M.
- Ken Griffin added most to Hess in Q1 2024, an estimated $1.28B increase.
- Ken Griffin's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.78B.
- Ken Griffin fully exited iShares National Muni Bond ETF in Q1 2024, selling an estimated $183M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q1 2024.
- Ken Griffin opened 1,749 new positions and closed 1,439 in Q1 2024.
- Ken Griffin's portfolio value rose 3.6% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.